Leo Pharma Eyes $800 Million Deal Push as IPO Plans Advance

Leo Pharma is actively seeking more acquisition targets, with as much as 5 billion kroner ($800 million) to spend on dealmaking as it positions itself for an initial public offering, according to its top management.